Modulation of PAX6 Homeodomain Function by the Paired Domain

Sanjaya Singh, Christine M. Stellrecht, Hank Kejun Tang, Grady F. Saunders

Journal of Biological Chemistry · 2000 · 43 citations · 46 references

DOIFull text

Open access

Concepts

Abstract

PAX6 is required for proper development of the eye, central nervous system, and nose. PAX6 has two DNA binding domains, a glycine-rich region that links the two DNA binding domains, and a transactivation domain. There is evidence that the different DNA binding domains of PAX6 have different target genes. However, it is not clear if the two DNA binding domains function independently. We have studied the effect of structural changes in the paired domain on the function of PAX6 mediated through its homeodomain. The R26G and I87R mutations have been reported in different human patients with clinically different phenotypes and are in the N- and the C-terminal halves of the paired domain, respectively. Surprisingly, we found that the I87R mutant protein not only lost the transactivation function but also failed to bind DNA by either of its DNA binding domains. In contrast, the R26G mutant protein lost DNA binding through its paired domain but had greater DNA binding and transactivation than wild-type PAX6 on homeodomain binding sites. Like R26G, the 5a isoform showed higher DNA binding than wild-type PAX6. This study demonstrates that the two subdomains of the paired domain influence the function of the homeodomain differentially and also provides an explanation for the difference in phenotypes associated with these mutations. PAX6 is required for proper development of the eye, central nervous system, and nose. PAX6 has two DNA binding domains, a glycine-rich region that links the two DNA binding domains, and a transactivation domain. There is evidence that the different DNA binding domains of PAX6 have different target genes. However, it is not clear if the two DNA binding domains function independently. We have studied the effect of structural changes in the paired domain on the function of PAX6 mediated through its homeodomain. The R26G and I87R mutations have been reported in different human patients with clinically different phenotypes and are in the N- and the C-terminal halves of the paired domain, respectively. Surprisingly, we found that the I87R mutant protein not only lost the transactivation function but also failed to bind DNA by either of its DNA binding domains. In contrast, the R26G mutant protein lost DNA binding through its paired domain but had greater DNA binding and transactivation than wild-type PAX6 on homeodomain binding sites. Like R26G, the 5a isoform showed higher DNA binding than wild-type PAX6. This study demonstrates that the two subdomains of the paired domain influence the function of the homeodomain differentially and also provides an explanation for the difference in phenotypes associated with these mutations. paired domain homeodomain neural cell adhesion molecule cytomegalovirus electrophoretic mobility shift assay proline-, serine-, and threonine-rich transactivation domain Pax6 is considered the master control gene for morphogenesis and evolution of the eye (1.Gehring W.J. Genes Cells. 1996; 1: 11-15Crossref PubMed Scopus (210) Google Scholar). It is an evolutionarily conserved gene in both vertebrates and invertebrates. ThePax6 genes cloned from representatives of at least eight animal phyla are structurally and functionally similar (2.Niimi T. Seimiya M. Kloter U. Flister S. Gehring W.J. Development. 1999; 126: 2253-2260Crossref PubMed Google Scholar), and ectopic expression of mouse and squid Pax6 in Drosophilaresults in ectopic eye formation (3.Halder G. Callaerts P. Gehring W.J. Science. 1995; 267: 1788-1792Crossref PubMed Scopus (1250) Google Scholar, 4.Tomarev S.I. Callaerts P. Kos L. Zinovieva R. Halder G. Gehring W. Piatigorsky J. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 2421-2426Crossref PubMed Scopus (159) Google Scholar). Pax6 is expressed in the developing eye, nose, pancreas, and central nervous system (5.Ton C.C. Hirvonen H. Miwa H. Weil M.M. Monaghan P. Jordan T. van Heyningen V. Hastie N.D. Meijers-Heijboer H. Drechsler M. Royer-Pokora B. Collins F. Swaroop A. Strong L.C. Saunders G.F. Cell. 1991; 67: 1059-1074Abstract Full Text PDF PubMed Scopus (738) Google Scholar, 6.Walther C. Gruss P. Development. 1991; 113: 1435-1449Crossref PubMed Google Scholar, 7.Turque N. Plaza S. Radvanyi F. Carriere C. Saule S. Mol. Endocrinol. 1994; 8: 929-938Crossref PubMed Scopus (111) Google Scholar, 8.Grindley J.C. Davidson D.R. Hill R.E. Development. 1995; 121: 1433-1442Crossref PubMed Google Scholar, 9.Davis J.A. Reed R.R. J. Neurosci. 1996; 16: 5082-5094Crossref PubMed Google Scholar, 10.Koroma B.M. Yang J.M. Sundin O.H. Invest. Ophthalmol. Visual Sci. 1997; 38: 108-120PubMed Google Scholar). Loss of PAX6 function leads to severe brain abnormalities, microencephaly, early postnatal death, and the absence of eyes and nose in rodents (11.Matsuo T. Osumi-Yamashita N. Noji S. Ohuchi H. Koyama E. Myokai F. Matsuo N. Taniguchi S. Doi H. Iseki S. Nat. Genet. 1993; 3: 299-304Crossref PubMed Scopus (256) Google Scholar, 12.Schmahl W. Knoedlseder M. Favor J. Davidson D. Acta Neuropathol. 1993; 86: 126-135Crossref PubMed Scopus (179) Google Scholar) and humans (13.Glaser T. Jepeal L. Edwards J.G. Young S.R. Favor J. Maas R.L. Nat. Genet. 1994; 7: 463-471Crossref PubMed Scopus (591) Google Scholar). In addition, PAX6 is also essential for the differentiation of α-cells and the formation of the islets in the pancreas (14.St.-Onge L. Sosa-Pineda B. Chowdhury K. Mansouri A. Gruss P. Nature. 1997; 387: 406-409Crossref PubMed Scopus (652) Google Scholar, 15.Sander M. Neubuser A. Kalamaras J. Ee H.C. Martin G.R. German M.S. Genes Dev. 1997; 11: 1662-1673Crossref PubMed Scopus (452) Google Scholar). Heterozygous mutations in thePAX6 gene are responsible for several naturally occurring phenotypes including aniridia. The PAX6 protein can be subdivided into several distinct domains. It has two DNA binding domains (a paired domain (PD)1 at the NH2terminus and a paired-like homeodomain (HD) in the middle), a glycine-rich region that links the two DNA binding domains, and a transactivation domain at the COOH terminus (5.Ton C.C. Hirvonen H. Miwa H. Weil M.M. Monaghan P. Jordan T. van Heyningen V. Hastie N.D. Meijers-Heijboer H. Drechsler M. Royer-Pokora B. Collins F. Swaroop A. Strong L.C. Saunders G.F. Cell. 1991; 67: 1059-1074Abstract Full Text PDF PubMed Scopus (738) Google Scholar, 16.Tang H.K. Singh S. Saunders G.F. J. Biol. Chem. 1998; 273: 7210-7221Abstract Full Text Full Text PDF PubMed Scopus (78) Google Scholar). There are two major alternatively spliced forms of PAX6 which differ by the presence or absence of 14 amino acids within the PD which are coded by an exon known as 5a (17.Epstein J.A. Glaser T. Cai J. Jepeal L. Walton D.S. Maas R.L. Genes Dev. 1994; 8: 2022-2034Crossref PubMed Scopus (317) Google Scholar). Studies suggest that the target genes of PAX6 can be regulated by three types of DNA binding sites: (i) those identified by the PD., e.g. mouse neural cell adhesion molecule (N-CAM) (18.Holst B.D. Wang Y. Jones F.S. Edelman G.M. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 1465-1470Crossref PubMed Scopus (59) Google Scholar); (ii) those identified by the HD, e.g. rhodopsin (19.Sheng G. Thouvenot E. Schmucker D. Wilson D.S. Desplan C. Genes Dev. 1997; 11: 1122-1131Crossref PubMed Scopus (155) Google Scholar); and (iii) those identified by cooperative interaction of the PD and HDe.g. N-CAM L1 (20.Chalepakis G. Wijnholds J. Giese P. Schachner M. Gruss P. DNA Cell Biol. 1994; 13: 891-900Crossref PubMed Scopus (77) Google Scholar). The PD of PAX6 can bind to a broad range of DNA sequences with high specificity. The PD actually consists of independent amino-terminal and carboxyl-terminal subdomains, and each subdomain can identify and bind to distinct DNA sequences (21.Czerny T. Schaffner G. Busslinger M. Genes Dev. 1993; 7: 2048-2061Crossref PubMed Scopus (349) Google Scholar, 22.Epstein J. Cai J. Glaser T. Jepeal L. Maas R. J. Biol. Chem. 1994; 269: 8355-8361Abstract Full Text PDF PubMed Google Scholar). However, recent crystallographic studies using a 26-base pair consensus PAX6-DNA binding site and full-length PD peptide revealed that the docking arrangements of the NH2 subdomain and COOH subdomain are very similar (23.Xu H.E. Rould M.A. Xu W. Epstein J.A. Maas R.L. Pabo C.O. Genes Dev. 1999; 13: 1263-1275Crossref PubMed Scopus (234) Google Scholar). However, it is not clear how the PAX6 PD recognizes so many different DNA sequences. PDs can also bind DNA by interacting with other DNA binding domains such as the HD (24.Underhill D.A. Vogan K.J. Gros P. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 3692-3696Crossref PubMed Scopus (49) Google Scholar, 25.Jun S. Desplan C. Development. 1996; 122: 2639-2650Crossref PubMed Google Scholar). In the PAX6 protein, the paired-type HD is about 80 amino acids downstream of the PD. Studies have shown that highly diverged HDs have indistinguishable DNA binding preferences (26.Wilson D. Sheng G. Lecuit T. Dostatni N. Desplan C. Genes Dev. 1993; 7: 2120-2134Crossref PubMed Scopus (328) Google Scholar). Several mechanisms have been suggested for the specificity of HD function. These include protein oligomerization mediated by dimerization domains outside of the HD, protein-protein interactions of homeoproteins with other factors, association of the HD with other DNA binding domains, and cooperative dimerization of paired class HDs (26.Wilson D. Sheng G. Lecuit T. Dostatni N. Desplan C. Genes Dev. 1993; 7: 2120-2134Crossref PubMed Scopus (328) Google Scholar). However, which of these mechanisms are utilized by PAX6 is not known. That the PD of PAX6 can bind to a broad range of DNA sequences and many HDs recognize similar sequences has hindered the identification of target genes of PAX6. Functional and DNA binding studies using PAX6 missense mutations with the observed developmental defects may be useful in determining how PAX6 recognizes DNA in the target genes and factors that influence binding site selection. In the present report we analyzed two PD missense mutations reported in human patients: R26G is in the NH2 subdomain and I87R is in the COOH subdomain of the PD of PAX6 (Fig.1). The patient with the R26G mutation had Peter's anomaly, and the patient with I87R had a much more severe phenotype and is described in detail in Tang et al. (27.Tang H.K. Chao L.Y. Saunders G.F. Hum. Mol. Genet. 1997; 6: PubMed Scopus Google Scholar). to crystallographic studies of a PD to a PAX6 consensus binding of these mutations is in DNA (23.Xu H.E. Rould M.A. Xu W. Epstein J.A. Maas R.L. Pabo C.O. Genes Dev. 1999; 13: 1263-1275Crossref PubMed Scopus (234) Google Scholar). We analyzed the transactivation and DNA binding of these with the HD DNA binding and and with three different PD binding sites. We have also the 5a isoform of PAX6 to study the effect of structural changes in the PD on the DNA binding function of the that the structural changes in the two subdomains of PD influence the DNA binding of the HD of PAX6 differentially and a explanation for the observed in phenotype the two a cell in essential with a human cell Invest. Ophthalmol. Visual Sci. 1994; Google Scholar), in essential with expression by using a The of the R26G and I87R is described (27.Tang H.K. Chao L.Y. Saunders G.F. Hum. Mol. Genet. 1997; 6: PubMed Scopus Google Scholar). the isoform of PAX6 to the or by two of the or sequences at the site in the T. Busslinger M. Mol. Cell. Biol. 1995; PubMed Scopus Google Scholar). and at a of or for with DNA with the to the at using of at using of with the expression each with of or of and of as an Cell of at using a assay of into of cell and of into the which into a for The to the for with a using a assay to The the as for the to from as described in detail S. Tang H.K. Saunders G.F. J. Biol. Chem. 1998; 273: Full Text Full Text PDF PubMed Scopus Google Scholar). The protein of by the assay and to protein by with the and using the system using the described The of PAX6 protein expressed or by with the region of PAX6 as described S. Tang H.K. Saunders G.F. J. Biol. Chem. 1998; 273: Full Text Full Text PDF PubMed Scopus Google Scholar). The on the by using a and of in by the and by using a and for PD DNA binding as described by al. S. Tang H.K. Saunders G.F. J. Biol. Chem. 1998; 273: Full Text Full Text PDF PubMed Scopus Google Scholar) and for HD DNA binding as described by al. (26.Wilson D. Sheng G. Lecuit T. Dostatni N. Desplan C. Genes Dev. 1993; 7: 2120-2134Crossref PubMed Scopus (328) Google Scholar). The and analyzed with a by on the binding with the PAX6 at for it the In report (27.Tang H.K. Chao L.Y. Saunders G.F. Hum. Mol. Genet. 1997; 6: PubMed Scopus Google Scholar), we that R26G and I87R mutant only DNA binding the PAX6 DNA binding site is We by using two other PAX6 PD binding T. Busslinger M. Mol. Cell. Biol. 1995; PubMed Scopus Google Scholar) and the binding site found in the region of mouse N-CAM gene (18.Holst B.D. Wang Y. Jones F.S. Edelman G.M. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 1465-1470Crossref PubMed Scopus (59) Google Scholar). The N-CAM binding region is structurally different from the other two it is two by for from of PAX6 and mutant PAX6 as by reported (27.Tang H.K. Chao L.Y. Saunders G.F. Hum. Mol. Genet. 1997; 6: PubMed Scopus Google Scholar), R26G and I87R DNA binding the PD binding site However, binding of mutant to the and N-CAM binding recent report the of PAX6 to PAX6 binding site showed that with DNA at site (23.Xu H.E. Rould M.A. Xu W. Epstein J.A. Maas R.L. Pabo C.O. Genes Dev. 1999; 13: 1263-1275Crossref PubMed Scopus (234) Google Scholar). This the that PAX6 may bind to different PD binding by DNA with different of amino of PD for DNA binding of PAX6 PD in a it is that the HD and PD bind of each other on we to by using PD PAX6 and HD DNA binding in a We both the consensus HD binding and for the with or and mutant or wild-type expression and for PAX6 the of the gene the with either of the HD binding R26G showed higher than wild-type I87R not with the the that transactivation by the I87R mutant protein may have been to a of I87R mutant protein, in with and of from the with the of expression using the The that of the similar of we the effect of wild-type and mutant as be the in a control we the expression which has a HD and an PD and can bind DNA only on PD DNA binding but not HD binding not the expression with the PAX6 and the R26G mutant showed and the and the I87R and not the R26G mutant expressed in the presence of wild-type in by PAX6 with the However, the I87R mutant with wild-type a in the of This may be to the effect of the domain in the I87R mutant In an report (27.Tang H.K. Chao L.Y. Saunders G.F. Hum. Mol. Genet. 1997; 6: PubMed Scopus Google Scholar), we showed that of the domain transactivation by PAX6. the effect not with the R26G the of transactivation it that the I87R mutant has an HD it may not bind to the DNA and transactivation However, I87R mutant has an domain, it of of wild-type PAX6. In contrast, the R26G mutant showed higher that it of DNA binding and with the for transactivation is on DNA we shift to the DNA binding of the mutant through the We HD binding and (24.Underhill D.A. Vogan K.J. Gros P. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 3692-3696Crossref PubMed Scopus (49) Google Scholar, D. Sheng G. Lecuit T. Dostatni N. Desplan C. Genes Dev. 1993; 7: 2120-2134Crossref PubMed Scopus (328) Google Scholar, D.A. Gros P. J. Biol. Chem. 1997; Full Text Full Text PDF PubMed Scopus Google Scholar) and for The of protein by a by with a as described of and are two of PAX6 can bind to these sites. both and and The specificity of the both and by with and PAX6 protein not We found that with PD binding a much higher of PAX6 protein required to binding and to either or the binding for the R26G and I87R the R26G mutant showed higher binding with in than wild-type but more the I87R mutant not binding in and in at higher of protein and a the it to be by protein of HD for DNA binding of PAX6 PD in a In and in may differ in shift also with the described in the for of with the of for the which as a control to the of the PAX6 with binding with I87R mutant protein the R26G mutant showed higher binding both as a and as a of or to the as a the PAX6 not with as binding not these are in with the transactivation higher HD binding by the R26G mutant and the absence of HD binding in the of the I87R mutant as these missense mutations are in the PD. The that the I87R mutation in of function mutation in the in the R26G mutant lost its function through the PD and had function mediated through its This be the I87R mutation in a more severe phenotype in Like the R26G which is in the the 5a isoform of PAX6 is by of 14 amino acids within the NH2 and changes its the R26G mutant showed higher DNA we to if other changes in the PD influence DNA binding through the described shift with of in and and the and binding sites. with the R26G the 5a isoform showed higher DNA binding and the in DNA binding wild-type the R26G and the 5a we binding studies as described by et al. (24.Underhill D.A. Vogan K.J. Gros P. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 3692-3696Crossref PubMed Scopus (49) Google Scholar), Vogan et al. K.J. D.A. Gros P. Mol. Cell. Biol. 1996; 16: PubMed Scopus Google Scholar), and Singh et al. S. Tang H.K. Saunders G.F. J. Biol. Chem. 1998; 273: Full Text Full Text PDF PubMed Scopus Google Scholar). These using of different with a of and a of protein with of In the of of of PAX6 and R26G mutant protein with of DNA or in a and on The on the The of these are in and B. The as described S. Tang H.K. Saunders G.F. J. Biol. Chem. 1998; 273: Full Text Full Text PDF PubMed Scopus Google Scholar) using The difference in R26G and PAX6 as and as The difference in 5a and PAX6 as a and as a The also revealed that at of PAX6 or mutant However, binding not and with a in protein, at and not within the of protein in the we had in the range to the are in with an report (26.Wilson D. Sheng G. Lecuit T. Dostatni N. Desplan C. Genes Dev. 1993; 7: 2120-2134Crossref PubMed Scopus (328) Google Scholar) that cooperative dimerization of paired class However, we full-length protein, which has a paired class HD in the of the also with the The binding that the R26G mutant had more than higher for HD binding site with PAX6 not the showed that mutations in the two subdomains of the PD influence the function of the HD in The that structural changes in the PD of PAX6 influence the function of its The also that the of the influence is on the of the structural This influence may be the for the difference in the phenotype of the two patients these mutations (27.Tang H.K. Chao L.Y. Saunders G.F. Hum. Mol. Genet. 1997; 6: PubMed Scopus Google Scholar). of Pax6 that the two domains can independently. In two types of Pax6 are a protein both domains and a protein with only the HD Nature. 1995; PubMed Scopus Google Scholar, Y. Nature. 1995; PubMed Scopus Google Scholar). The presence of the HD in a protein that it can function independently. In addition, in binding studies have that the PD and HD bind to different consensus and each domain has been with its consensus (17.Epstein J.A. Glaser T. Cai J. Jepeal L. Walton D.S. Maas R.L. Genes Dev. 1994; 8: 2022-2034Crossref PubMed Scopus (317) Google Scholar, 22.Epstein J. Cai J. Glaser T. Jepeal L. Maas R. J. Biol. Chem. 1994; 269: 8355-8361Abstract Full Text PDF PubMed Google H.E. Rould M.A. Xu W. Epstein J.A. Maas R.L. Pabo C.O. Genes Dev. 1999; 13: 1263-1275Crossref PubMed Scopus (234) Google Scholar, D.S. B. Desplan C. J. Cell. 1995; Full Text PDF PubMed Scopus Google Scholar, W. Rould M.A. S. Desplan C. Pabo C.O. Cell. 1995; Full Text PDF PubMed Scopus Google Scholar, G. Gruss P. 1995; PubMed Scopus Google Scholar). There is evidence from gene studies that the two DNA binding domains have different target sequences. genes and of the gene have that are by the PD of PAX6 (2.Niimi T. Seimiya M. Kloter U. Flister S. Gehring W.J. Development. 1999; 126: 2253-2260Crossref PubMed Google Scholar, B.D. Wang Y. Jones F.S. Edelman G.M. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 1465-1470Crossref PubMed Scopus (59) Google Scholar, J. N. Y. Acad. Sci. 1998; PubMed Scopus Google Scholar), other genes rhodopsin (19.Sheng G. Thouvenot E. Schmucker D. Wilson D.S. Desplan C. Genes Dev. 1997; 11: 1122-1131Crossref PubMed Scopus (155) Google Scholar) and L1 cell adhesion molecule gene R. P. Edelman G.M. Jones F.S. Proc. Natl. Acad. Sci. U. S. A. 1999; PubMed Scopus Google Scholar) have that are by the HD of PAX6. studies that expression of gene is by to its HD binding on a in the region M.A. J. Biol. Chem. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar, B. A. N. Saule S. J. J. Biol. Chem. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar). In to the studies by et al. (24.Underhill D.A. Vogan K.J. Gros P. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 3692-3696Crossref PubMed Scopus (49) Google Scholar) on the mouse mutation the of the two DNA binding domains in The mutation is a to at of the PD which is at the of a studies showed that structural of is essential for DNA binding function of by either of its DNA binding domains D.A. Gros P. J. Biol. Chem. 1997; Full Text Full Text PDF PubMed Scopus Google Scholar). The HDs of the paired class have diverged from those of the and N. P. Hill R.L. Davidson Genes Dev. PubMed Scopus Google Scholar). HD bind target as paired HD to DNA as a in (26.Wilson D. Sheng G. Lecuit T. Dostatni N. Desplan C. Genes Dev. 1993; 7: 2120-2134Crossref PubMed Scopus (328) Google Scholar). In studies with and the full-length which PAX6 also a has paired HD, showed that not only dimerization but the binding cooperative (24.Underhill D.A. Vogan K.J. Gros P. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 3692-3696Crossref PubMed Scopus (49) Google Scholar), as in binding with or and the of binding that full-length PAX6 dimerization is This dimerization than wild-type PAX6 with both the 5a isoform and R26G mutant can be into distinct to in the PD C. Gruss P. Development. 1991; 113: 1435-1449Crossref PubMed Google Scholar). has binding preferences for distinct binding sites. of the by PAX6 binding to the two distinct types of sequences by the of the and (21.Czerny T. Schaffner G. Busslinger M. Genes Dev. 1993; 7: 2048-2061Crossref PubMed Scopus (349) Google Scholar), that the of the PD region in different may be It is that different of the PD may influence the function of the HD of genes in developmental highly conserved The of specificity different HD be on the of the DNA binding specificity of the HDs (26.Wilson D. Sheng G. Lecuit T. Dostatni N. Desplan C. Genes Dev. 1993; 7: 2120-2134Crossref PubMed Scopus (328) Google Scholar). of the may on interaction with protein outside the HD to specificity. paired DNA binding domains are an G. R. H. U. M. Gruss P. Cell. 1991; Full Text PDF PubMed Scopus Google Scholar, G. P. Gruss P. J. Cell Sci. 16: PubMed Google Scholar). and studies (24.Underhill D.A. Vogan K.J. Gros P. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 3692-3696Crossref PubMed Scopus (49) Google Scholar, D.A. Gros P. J. Biol. Chem. 1997; Full Text Full Text PDF PubMed Scopus Google Scholar) a clear that PD the HD and is to be in specificity and (24.Underhill D.A. Vogan K.J. Gros P. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 3692-3696Crossref PubMed Scopus (49) Google Scholar, D.A. Gros P. J. Biol. Chem. 1997; Full Text Full Text PDF PubMed Scopus Google Scholar). several missense mutations have been identified in thePAX6 gene from the patient so the absence of missense mutations in the HD is for are that missense mutations in the HD are and not and that amino in the HD by missense mutations not in phenotypes and The PAX6 gene is highly and structural of several human in the HD or PD have been the of mutations. is considered a and as a of of function of of PAX6 (5.Ton C.C. Hirvonen H. Miwa H. Weil M.M. Monaghan P. Jordan T. van Heyningen V. Hastie N.D. Meijers-Heijboer H. Drechsler M. Royer-Pokora B. Collins F. Swaroop A. Strong L.C. Saunders G.F. Cell. 1991; 67: 1059-1074Abstract Full Text PDF PubMed Scopus (738) Google Scholar, T. Walton D.S. Maas R.L. Nat. Genet. PubMed Scopus Google Scholar). However, the in the expression of be by present study in with other S. Tang H.K. Saunders G.F. J. Biol. Chem. 1998; 273: Full Text Full Text PDF PubMed Scopus Google Scholar, M. G. P. R. 1998; PubMed Scopus Google Scholar, R. P. Mol. 1998; PubMed Scopus Google Scholar, G. G. M. H. Biol. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar, F. J. Ophthalmol. 1998; 126: Full Text Full Text PDF PubMed Scopus Google Scholar) that are factors that may to the in the expression of aniridia. more and more missense mutations with known phenotypes are analyzed for DNA binding and the of PAX6 DNA binding and it may be to the effect of a mutation at a We R. and M. Busslinger for the We are to for the The DNA by the at M. D.

References

46